Why Is Croda Up Today?

Croda International Plc (LSE:CRDA) shares rose 1.25% to 3,809p on 16 Nov 2026, leaving the speciality chemicals group higher on the London market. Price moves within a single session often track wider market conditions and sector sentiment, and they sit alongside, rather than replace, the picture given by a company's published results.

The company's latest scheduled update, its third-quarter 2026 sales statement published on 5 November 2026, showed group sales of GBP 449.9 million, up 5.9% as reported and 6.6% on an organic basis.

Croda left its full-year 2026 outlook unchanged.

Key Highlights

Q3 sales were GBP 449.9 million, compared with GBP 424.7 million a year earlier.

Consumer Care Organic Sales grew 10.8%, with double-digit growth in Beauty Actives and Beauty Care.

Life Sciences grew 1.8% organically, with Pharma and Seed Enhancement offsetting weaker Crop Protection.

The company remains on track for its transformation plan and FY28 financial framework.

About Croda

Croda International Plc, listed as LSE:CRDA, is a speciality chemicals company founded in 1925 that supplies ingredients for beauty, pharmaceuticals, crop protection, flavours and fragrances, and industrial uses.

Its FY28 targets include organic sales growth of 3% to 6% and an adjusted profit Margin above 20%.

Third-Quarter Trading

Beauty Actives sales were particularly high in North America and Asia, supported by increased innovation activity. Fragrances and Flavours grew about 4% organically, affected by Middle East disruption and temporary interruptions to sales in China during a production Facility transfer.

Lower Crop Protection sales, particularly in the Americas, remained a drag on the Life Sciences division.

Context from Earlier in the Year

In the first quarter, sales fell 2.5% to GBP 431 million, though they rose 1% at constant exchange rates, after demanding comparators in 2025. The third quarter therefore marks a faster pace of organic growth, above the medium-term range of 3% to 6%.

Outlook

Croda continues to expect group organic sales growth within its 3% to 6% range for 2026. The company said it is focusing sales resources on key customer segments where it creates the most value.

What Investors Should Watch Next

Readers following LSE:CRDA may focus on the durability of Beauty demand, Crop Protection trends, the Middle East and the full-year 2026 results.

Conclusion

Croda shares rose 1.25% to 3,809p on 16 Nov 2026, following a third-quarter update with organic sales up 6.6% and an unchanged outlook.

Beauty growth, Pharma and Crop Protection are the main themes for investors.